Skip to main content

Table 4 Differences in clinicopathological factors according to the primary tumor’s SUVmax

From: Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study

 

Total (n = 60)

Primary tumor’s SUVmax

P value

High

Low

Sex

 Male

46

23

23

1.000

 Female

14

6

8

 

Age

 < 70 years

28

14

14

0.7961

 ≥ 70 years

32

15

17

 

Histological type

 Adenocarcinoma

27

8

19

0.0108*

 Non-adenocarcinoma

33

21

12

 

Tumor size

 ≤ 30 mm

19

3

16

< 0.0001*

 > 30 mm

41

26

15

 

CEA

 < 5.0 ng/mL

30

11

19

0.1205

 ≥ 5.0 ng/mL

30

18

12

 

Pathological N status ng/mL

 pN0

23

9

14

0.2106

 pN1

22

14

8

 

 pN2

15

6

9

 
  1. *P < 0.05